As of 2025-04-29, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (25.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.30 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -2039.7%.
The range of the Relative Valuation is (23.39) - (25.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 24.5x | 24.1x |
| Forward P/E multiples | 21.1x - 22.9x | 21.3x |
| Fair Price | (23.39) - (25.44) | (25.22) |
| Upside | -1899.6% - -2056.8% | -2039.7% |
| Date | P/E |
| 2025-04-25 | -1.17 |
| 2025-04-24 | -1.14 |
| 2025-04-23 | -1.14 |
| 2025-04-22 | -1.05 |
| 2025-04-21 | -0.99 |
| 2025-04-17 | -0.98 |
| 2025-04-16 | -0.99 |
| 2025-04-15 | -1.07 |
| 2025-04-14 | -1.13 |
| 2025-04-11 | -1.12 |
| 2025-04-10 | -1.02 |
| 2025-04-09 | -1.11 |
| 2025-04-08 | -0.93 |
| 2025-04-07 | -1.05 |
| 2025-04-04 | -1.05 |
| 2025-04-03 | -1.10 |
| 2025-04-02 | -1.22 |
| 2025-04-01 | -1.22 |
| 2025-03-31 | -1.25 |
| 2025-03-28 | -1.29 |
| 2025-03-27 | -1.34 |
| 2025-03-26 | -1.31 |
| 2025-03-25 | -1.39 |
| 2025-03-24 | -1.50 |
| 2025-03-21 | -1.53 |
| 2025-03-20 | -1.51 |
| 2025-03-19 | -1.51 |
| 2025-03-18 | -1.46 |
| 2025-03-17 | -1.40 |
| 2025-03-14 | -1.35 |
| 2025-03-13 | -1.33 |
| 2025-03-12 | -1.41 |
| 2025-03-11 | -1.47 |
| 2025-03-10 | -1.39 |
| 2025-03-07 | -1.43 |
| 2025-03-06 | -1.40 |
| 2025-03-05 | -1.44 |
| 2025-03-04 | -1.46 |
| 2025-03-03 | -1.40 |
| 2025-02-28 | -1.47 |
| 2025-02-27 | -1.49 |
| 2025-02-26 | -1.58 |
| 2025-02-25 | -1.60 |
| 2025-02-24 | -1.64 |
| 2025-02-21 | -1.85 |
| 2025-02-20 | -1.85 |
| 2025-02-19 | -1.98 |
| 2025-02-18 | -1.92 |
| 2025-02-14 | -2.08 |
| 2025-02-13 | -2.03 |